# Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms

> **NCT02430779** · NA · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 30 (actual)

## Conditions studied

- Renal Pelvic and Ureteral Neoplasms

## Interventions

- **PROCEDURE:** rreversible electroporation (IRE)
- **DEVICE:** NanoKnife

## Key facts

- **NCT ID:** NCT02430779
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430779, "Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02430779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*